Vascular Solutions Inc.

Robbins Arroyo LLP Is Investigating the Officers and Directors of Vascular Solutions, Inc. (VASC) on Behalf of Shareholders

Robbins Arroyo LLP is investigating whether certain officers and directors of Vascular Solutions, Inc. (NASDAQ: VASC) breached their fiduciary duties to shareholders. Vascular Solutions is a medical device company that provides various solutions to interventional cardiologists, interventional radiologists, electro physiologists, and vein practices worldwide.

Vascular Solutions Indicted for Conspiring to Defraud the United States

On November 13, 2014, a federal grand jury in the Western District of Texas returned an indictment against Vascular Solutions and the company’s Chief Executive Officer, Howard Root. According to an announcement by the U.S. Department of Justice, Vascular Solutions and Mr. Root were each charged with selling medical devices without U.S. Food and Drug Administration (“FDA”) approval and conspiring to defraud the United States through the concealment of the illegal sales activity. Specifically, the indictment alleges that the company maintained a deceptive sales campaign for its Vari-Lase product line, which had received FDA approval for the treatment of superficial veins. Rather than limit its sales to the treatment of superficial veins, Vascular Solutions sold the products for the much riskier treatment of ablating “perforator” veins. On this news, shares of Vascular Solutions stock fell over 22%, to close at $23.74 on November 14, 2014.

Vascular Solutions Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.

 

Shareholder Information

Items marked with an asterisk (*) are required information.

First Name * Last Name *
Address City State/Province *
ZIP/Postal Code Country/Region Phone *
E-mail * Confirm: E-mail *

Shares Purchased:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Shares Sold:
Number of Shares: Sell Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* I have read the disclaimer information
+=

    Send This Post

    Tags: